Nuclear Antigen anticorps
-
- Antigène Voir toutes Nuclear Antigen (IPO-38) Anticorps
- Nuclear Antigen (IPO-38)
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Nuclear Antigen est non-conjugé
-
Application
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), ELISA, Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Specificité
- Reacts with human Proliferation Marker IPO-38. This antigen was detected after 12 h of PHA-induced activation in the early G1 phase but absent in non-stimulated lymphocytes.
- Purification
- Purified (protein A)
- Immunogène
- Spleen cells of a human patient with hairy cell leukemia.
- Clone
- Clon IPO-38
- Top Product
- Discover our top product IPO-38 Anticorps primaire
-
-
- Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
ELISA (1:10000 - 1:50000) IHC - F, IHC - P (10 μg/mL) IP, WB (1:500 - 1:2000) - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- 0.02 M potassium phosphate, 0.5 M NaCl, pH 7.2
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Long term: -20°C, Short term: -20°C
-
- Antigène
- Nuclear Antigen (IPO-38)
- Autre désignation
- Proliferation Marker IPO-38 (IPO-38 Produits)
-